AMF Medical announced today that it received FDA breakthrough device designation for its Sigi insulin management system.
Ecublens, Switzerland-based AMF Medical’s Sigi (for diabetes mellitus treatment) can be programmed to deliver basal and bolus insulin at both set and variable rates.
Get the full story at our sister site, Drug Delivery Business News.